NEUROPACE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.665 USD | -3.46% |
|
-9.58% | -24.93% |
| 13/05 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
| 08/05 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
c840807a5bbe441.LqQcC9fj5IfNgz01k2Ikn8Vjo13_Wjf6sQwJYoI9X4A.YNVWZeGSrcmUyHFb5A5s75AT4g_NOV6X3kNoCLAEPLN3wStv7tSA8qrCZA~40a12b14d37cf57c11ada85b43cd72d9
